FY2017 Earnings Forecast for Henry Schein, Inc. (HSIC) Issued By Northcoast Research

Henry Schein, Inc. (NASDAQ:HSIC) – Analysts at Northcoast Research decreased their FY2017 earnings estimates for Henry Schein in a research note issued to investors on Tuesday. Northcoast Research analyst E. Snyder now forecasts that the company will earn $7.35 per share for the year, down from their previous estimate of $7.38. Northcoast Research has a “Buy” rating and a $218.00 price objective on the stock. Northcoast Research also issued estimates for Henry Schein’s Q2 2018 earnings at $1.99 EPS and FY2018 earnings at $8.19 EPS.

HSIC has been the subject of several other reports. Credit Suisse Group reaffirmed a “hold” rating and set a $160.00 price objective on shares of Henry Schein in a research note on Thursday, July 13th. Barrington Research upped their price objective on Henry Schein from $196.00 to $198.00 and gave the company an “outperform” rating in a research note on Wednesday, May 10th. Zacks Investment Research raised Henry Schein from a “hold” rating to a “buy” rating and set a $204.00 price objective for the company in a research note on Thursday, May 25th. Stifel Nicolaus upped their price objective on Henry Schein from $174.00 to $178.00 and gave the company a “hold” rating in a research note on Wednesday, May 10th. Finally, Piper Jaffray Companies began coverage on Henry Schein in a research note on Monday, June 12th. They set a “neutral” rating and a $200.00 price objective for the company. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and seven have given a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $185.56.

WARNING: “FY2017 Earnings Forecast for Henry Schein, Inc. (HSIC) Issued By Northcoast Research” was reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this article on another website, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The original version of this article can be viewed at https://www.com-unik.info/2017/08/12/fy2017-earnings-forecast-for-henry-schein-inc-hsic-issued-by-northcoast-research.html.

Shares of Henry Schein (NASDAQ:HSIC) opened at 170.58 on Thursday. Henry Schein has a 12-month low of $146.23 and a 12-month high of $186.99. The firm has a market capitalization of $13.49 billion, a price-to-earnings ratio of 24.93 and a beta of 1.09. The company’s 50-day moving average price is $181.54 and its 200 day moving average price is $175.12.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, August 8th. The company reported $1.75 EPS for the quarter, topping the consensus estimate of $1.73 by $0.02. The firm had revenue of $3.06 billion for the quarter, compared to analyst estimates of $3.05 billion. Henry Schein had a return on equity of 19.91% and a net margin of 4.59%. Henry Schein’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period last year, the company earned $1.64 earnings per share.

A number of institutional investors have recently added to or reduced their stakes in the company. Eads & Heald Investment Counsel boosted its position in Henry Schein by 0.5% in the second quarter. Eads & Heald Investment Counsel now owns 1,497 shares of the company’s stock valued at $274,000 after buying an additional 8 shares during the last quarter. Girard Partners LTD. boosted its position in Henry Schein by 0.3% in the first quarter. Girard Partners LTD. now owns 3,115 shares of the company’s stock valued at $529,000 after buying an additional 10 shares during the last quarter. Cleararc Capital Inc. boosted its position in Henry Schein by 0.6% in the first quarter. Cleararc Capital Inc. now owns 1,950 shares of the company’s stock valued at $331,000 after buying an additional 11 shares during the last quarter. Intrust Bank NA boosted its position in Henry Schein by 1.1% in the second quarter. Intrust Bank NA now owns 1,219 shares of the company’s stock valued at $223,000 after buying an additional 13 shares during the last quarter. Finally, Penserra Capital Management LLC boosted its position in Henry Schein by 1.0% in the first quarter. Penserra Capital Management LLC now owns 1,518 shares of the company’s stock valued at $258,000 after buying an additional 15 shares during the last quarter. Institutional investors own 90.87% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

What are top analysts saying about Henry Schein Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Henry Schein Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit